Ying Huang
Stock Analyst at B of A Securities
(2.56)
# 2,008
Out of 4,810 analysts
38
Total ratings
53.57%
Success rate
10.89%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $555 → $567 | $500.49 | +13.29% | 12 | Mar 31, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $105.68 | -31.87% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $29.06 | +61.73% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $6.55 | +1,121.37% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $1.00 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $0.63 | +6,234.13% | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | $3,700 → $4,360 | $4.47 | +97,439.15% | 1 | Feb 22, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $2.96 | +3,785.14% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $0.72 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $116.98 | +212.02% | 1 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $33 | $1.35 | +2,344.44% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $295.30 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Mar 31, 2025
Maintains: Buy
Price Target: $555 → $567
Current: $500.49
Upside: +13.29%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $105.68
Upside: -31.87%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $29.06
Upside: +61.73%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $6.55
Upside: +1,121.37%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $1.00
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $0.63
Upside: +6,234.13%
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: $3,700 → $4,360
Current: $4.47
Upside: +97,439.15%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $2.96
Upside: +3,785.14%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.72
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $116.98
Upside: +212.02%
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $1.35
Upside: +2,344.44%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $295.30
Upside: -